Stock CATX PERSPECTIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Real-time Estimate Cboe BZX
Other stock markets
 03:14:38 2024-05-13 pm EDT 		5-day change 1st Jan Change
1.715 USD -2.00% Intraday chart for Perspective Therapeutics, Inc. -5.46% +330.35%
May. 09 Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating MT
Apr. 30 Perspective Therapeutics, Inc. Announces the Selection of Investigational Product VMT-a-NET for the Treatment of Certain Patients with Neuroendocrine Tumors by the U.S. Food and Drug Administration to Participate in the Chemistry CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Medical Equipment, Supplies & Distribution

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PERSPECTIVE THERAPEUTICS, INC. Stock Perspective Therapeutics, Inc.
 1.03B - - - - -
ABBOTT LABORATORIES Stock Abbott Laboratories
 182B
MEDTRONIC PLC Stock Medtronic plc
 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
 68.11B
DEXCOM, INC. Stock DexCom, Inc.
 50.53B
CENCORA, INC. Stock Cencora, Inc.
 44.8B
  1. Stock Market
  2. Equities
  3. CATX Stock
  4. Charts Perspective Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW